High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction technique

Journal of Chromatography B: Biomedical Applications

Volumn 709, Issue 1, 1998, Pages 113-117

  Khan, Parveen ^a   McGown, Alan T ^a   Dawson, Martin J ^a   Jayson, Gordon ^b   Prendiville, Joseph A ^a   Pettit, George R ^c   Crowther, Derek ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CRC Department of Medical Oncology   (United Kingdom)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Bryostatin 1

Indexed keywords

BRYOSTATIN 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HORSES; HUMANS; LACTONES; MACROLIDES;

EID: 0032496249     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(98)00007-3     Document Type: Article

References (6)

1. Pettit B.R., Herald S.L., Daubek D.L., Arnold E., Clardy J. J. Am. Chem. Soc. 104:1982;6846.
2. Wender P.A., Cribbs C.M., Kohler K.F., Sharkey N., Herald C.L., Kamano Y., Pettit G.R., Blumberg P.M. Proc. Natl. Acad. Sci. USA. 85:1988;7197.
3. J.C. Baer, J.A. Slack (not published).
4. Carr M.E., Carr S.L., Grant S. Anti-Cancer Drugs. 6:1995;384.
5. Zhang X., Zhang R., Zhao H., Cai H., Gush A.K., Kerr R., Pettit G.R., Kraft A.S. Cancer Res. 56(4):1996;802.
6. Prendiville J.A., Crowther D., Thatcher N., Woll P.J., Fox B., McGown A., Testa N., Stern P., McDermott R., Potter M., Pettit G.R. Br. J. Cancer. 68:1993;418.